Table 1 Basic characteristics of participants (n = 1,234)
|  | Age at cancer diagnosis, mean (SD) | Total (n = 1,234) | Male (n = 690) | Female (n = 544) | p-value |
|---|---|---|---|---|---|
| Â | 51.45 (10.17) | Â | Â | Â | Â |
Age at cancer diagnosis (years) | |||||
 ≤ 39 |  | 166 | 32 | 134 |  < 0.001* |
40–49 |  | 325 | 104 | 221 |  |
50–59 |  | 439 | 284 | 155 |  |
 ≥ 60 |  | 304 | 270 | 34 |  |
Time from cancer diagnosis (years) | |||||
 ≤ 4 | 54.38 (10.14) | 519 | 314 | 205 | 0.019* |
5–9 | 51.25 (9.72) | 413 | 221 | 192 |  |
 ≥ 10 | 46.70 (8.93) | 302 | 155 | 147 |  |
Cancer stage | |||||
Early (0, I) | 50.88 (10.29) | 711 | 391 | 320 | 0.447 |
Advanced(II-) | 52.24 (9.95) | 523 | 299 | 224 | Â |
Cancer site | |||||
Intestinal | 55.11 (7.91) | 199 | 160 | 39 |  < 0.001* |
Gastric | 54.87 (9.01) | 156 | 126 | 30 | Â |
Breast | 47.08 (7.41) | 230 | 1 | 229 | Â |
Female genital | 40.61 (9.64) | 152 | 0 | 152 | Â |
Male genital | 60.64 (6.71) | 111 | 111 | 0 | Â |
Lung | 56.50 (7.33) | 52 | 43 | 9 | Â |
Urinary | 54.60 (7.82) | 101 | 88 | 13 | Â |
Hematological | 50.26 (10.60) | 66 | 47 | 19 | Â |
Head and neck | 48.38 (9.96) | 92 | 52 | 40 | Â |
Other | 53.55 (8.96) | 75 | 62 | 13 | Â |
Surgery | |||||
No | 53.37 (10.74) | 253 | 195 | 58 |  < 0.001* |
Yes | 50.96 (9.96) | 981 | 495 | 486 | Â |
Chemotherapy | |||||
No | 52.05 (10.35) | 817 | 477 | 340 | 0.014* |
Yes | 50.29 (9.70) | 417 | 213 | 204 | Â |
Radiotherapy | |||||
No | 52.07 (10.30) | 945 | 577 | 368 |  < 0.001* |
Yes | 49.43 (9.46) | 289 | 113 | 176 | Â |